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Abstract 9 
 20 
Deletions in the 15q11.2 region of the human genome are associated with neurobehavioral 21 
deficits, speed and motor delay as well as in some cases, symptoms of autism of 22 
schizophrenia. The cytoplasmic FMRP-interacting protein 1 (CYFIP1) is one of the four genes 23 
contained within this locus and has been associated with other genetic forms of Autism 24 
Spectrum Disorders (ASD). In mice, Cyfip1 haploinsufficiency leads to alteration of dendritic 25 
spine morphology and defects in synaptic plasticity, two pathophysiological hallmarks of 26 
mouse models of ASD. At the behavioral level, however, Cyfip1 haploinsufficiency leads to 27 
minor phenotypes, not directly relevant for 15q11.2 deletion syndrome or ASD. A 28 
fundamental question is whether neuronal phenotypes caused by the mutation of Cyfip1 are 29 
relevant for the human condition. Here, we unraveled the existence of a synaptic cluster of 30 
ASD-associated proteins centered on CYFIP1 and the adhesion protein Neuroligin-3. Cyfip1 31 
haploinsufficiency in mice led to decreased dendritic spine density and stability associated 32 
with social behavior and motor learning phenotypes. Behavioral training early in 33 
development resulted in alleviating the motor learning deficits caused by Cyfip1 34 
haploinsufficiency.  Altogether, these data provide new insight into the neuronal and 35 
behavioral phenotypes caused by Cyfip1 mutation and proof-of-concept for the 36 
development of a behavioural therapy to treat phenotypes associated with 15q11.2 37 
syndromes and ASD. 38 
 39 
Introduction 40 
Autism spectrum disorders (ASD) are defined by persistent deficits in social communication 41 
and social interaction accompanied by restricted, repetitive patterns of behavior, interests, 42 
or activities. In addition to these core symptoms, more than 70% of individuals with ASD 43 
have co-occurring medical, developmental or psychiatric conditions1. An extensive variety of 44 
impairments affecting gross and fine motor functions affect more than 79% of individuals 45 
with ASD1. Despite the frequency of motor anomalies, studies on the underlying 46 
pathophysiology of motor deficits and their treatment remain limited.  47 
Deletions in the 15q11.2 region of the human genome are associated with neurobehavioral 48 
deficits, speed and motor delay and, in about 30% of individuals, symptoms of autism2. The 49 
15q11.2 locus contains four genes, tubulin gamma complex associated protein 3 (TUBGCP3), 50 
cytoplasmic FMR1 interacting protein 1 (CYFIP1) and non-imprinted in Prader-51 
Willi/Angelman syndrome 1 and 2 (NIPA1/2)), and is also associated with larger 15q11–q13 52 
type I deletions causing Prader-Willi or Angelman Syndromes3. Microdeletions of 15q11.2 53 
correlated with decreased TUBGCP3, CYFIP1 and NIPA1/2 mRNA levels in lymphoblastoid 54 
cells derived from patients with Prader-Willi syndrome4. The four genes in the 15q11.2 locus 55 
were shown to impact on the behavioral symptoms of patients with 15q11.2 deletion or 56 
Prader-Will syndrome. In addition, decreased CYFIP1 mRNA levels were also found in 57 
leukocytes obtained from ASD diagnosed patients with Fragile X and in patients diagnosed 58 
with autism and carrying a deletion of SH3 and multiple ankyrin repeat domains 2 (SHANK2) 59 
gene.  60 
Amongst the genes within region 15q11.2, CYFIP1 is of particular interest due to its role in 61 
the control of actin dynamics5, 6 and protein translation7. This regulation occurs through its 62 
interaction with the Wiskott-Aldrich syndrome protein family verprolin-homologous protein 63 
(WAVE) regulatory complex (WRC)5, 6, and fragile X mental retardation protein (FMRP)7 64 
respectively. Hippocampal neurons with Cyfip1 haploinsufficiency show defects in dendritic 65 
spine morphogenesis and increase in metabotropic glutamate receptor-induced long-term 66 
depression8, 9, two phenotypes consistently found in mouse models for ASD and in particular 67 
Fragile X syndrome10-12. Importantly, analyses of post-mortem tissue of individuals with 68 
idiopathic and syndromic forms of ASD also showed alteration of dendritic spine 69 
morphology11. These results show that the effects of deletion of Cyfip1 resemble the cellular 70 
phenotypes found in other models of ASD. However, mice heterozygous for Cyfip1 71 
(Cyfip1HET) show mild behavioral phenotypes8, 13. It is, therefore, possible that CYFIP1 72 
function at synapses is not relevant for ASD or that the behavioral phenotyping of Cyfip1HET 73 
mice was not conducted extensively enough. 74 
Within the WRC, CYFIP1 and Abi interactor proteins 1-3 (ABI1-3) form an interaction surface 75 
that enables the interaction with proteins containing a WRC interacting receptor sequence 76 
(WIRS). The coding sequence of synaptic adhesion proteins Neuroligin-3 contains a WIRS and 77 
is therefore predicted to interact with CYFIP1 and ABI 1-3. The gene coding for these 78 
proteins has been associated with ASD in humans14-19. A putative interaction between 79 
Neuroligin-3, CYFIP1, and FMRP would point towards a possible common pathway linking 80 
ASD-associated proteins in synapses. Mice lacking Neuroligin-3 or FMRP show defects of 81 
social behavior and motor learning deficits correlated20-25 with alterations of dendritic spine 82 
stability26, 27. Based on this predicted interaction, we hypothesized that Cyfip1Het mice also 83 
show defects in social and motor behaviors. This study examines these possibilities by 84 
immunoprecipitation paired with mass-spectrometry, analysis of dendritic spines plasticity 85 
in vivo and behavioral analysis. Based on the results obtained, we investigated the possibility 86 
to rescue Cyfip1HET mice motor learning phenotype using a behavioral approach. 87 
 88 
Results 89 
The interaction between Neuroligin-3 and CYFIP1 was investigated using 90 
immunoprecipitation of Neuroligin-3 in striatum, cerebellum, and cortex, followed by 91 
western blot analysis. Neuroligin-3 co-immunoprecipitates Neuroligin-1 and 2, two 92 
previously characterized interactors of Neuroligin-328, and CYFIP1 (Figure 1A). CYFIP1 was 93 
detected in the three different brain regions indicating that the interaction between 94 
Neuroligin-3 and CYFIP1 is not restricted to a particular brain region.  Note that FMRP was 95 
not detected in these samples. Further investigations revealed that CYFIP1 was also present 96 
in Neuroligin-3 immunoprecipitates from synaptosomes but again FMRP was not 97 
(Supplementary Figure 1A).  Neuroligin-3 is expressed in neurons but also in astrocytes29. To 98 
determine if the interaction between Neuroligin-3 and CYFIP1 occurs in neurons, 99 
immunoprecipitations were performed on brain samples originating from mice expressing 100 
Neuroligin-3 only in Pvalb-expressing neurons (Nlgn3KOPvalbCre), as we previously showed 101 
that re-expressing Neuroligin-3 in these cells was sufficient to restore the ASD-related 102 
deficits in Nlgn3 knockout mice21.  Neuroligin-3 neuronal co-immunoprecipitated proteins 103 
from the three brain regions contained Neuroligin-2 and CYFIP1, indicating that indeed 104 
interaction between these proteins occurs in neurons and is not grossly influenced by the 105 
regional localization of Pvalb-expressing neurons (Figure 1B). Interestingly, proteins from 106 
Nlgn3KOPvalbCre, co-immunoprecipitated with Neuroligin-3, did not contain Neuroligin-1 but 107 
did contain FMRP, suggesting that the identity of the proteins interacting with the 108 
Neuroligin-3/CYFIP1 complex vary depending on the cell type.  109 
Studies suggest that CYFIP1 interaction with FMRP and WRC is mutually exclusive7. To 110 
determine if the Neuroligin-3/CYFIP1 complex interacts exclusively with FMRP or also 111 
contains components of the WRC we performed an unbiased screen of Neuroligin-3 co-112 
immunoprecipitated proteins using mass-spectrometry. The synapse-specific interactome of 113 
Neuroligin-3 was investigated, in vivo, in Nlgn3KOPvalbCre mice tissue (N = 3, supplementary 114 
Table 1), and in tissue expressing Neuroligin-3 but lacking synapses (N = 3, supplementary 115 
Table 2), as a control. The so-called olfactory ensheathing cells (OEC) populating the 116 
vomeronasal organ (VNO) fulfill these criteria as they are known to express Neuroligin-330, 117 
but are entirely devoid of synapses. Note that, biochemical analysis and in situ hybridization 118 
demonstrated that Neuroligin-3 is expressed in non-neuronal cells in the VNO, confirming its 119 
expression in OEC (supplementary Figure 2A-D). To determine proteins specifically 120 
associated with Neuroligin-3 in Pvalb-expressing interneurons, we performed co-121 
immunoprecipitation of Neuroligin-3 coupled with mass-spectrometry analysis and included 122 
co-immunoprecipitation of the VNOs of wild-type (N = 3, supplementary Table 2) and 123 
Nlgn3KO mice (N = 2) to our analysis to control for non-neuronal co-immunoprecipitated 124 
proteins and unspecific binding of the Neuroligin-3 antibody respectively (Supplementary 125 
Tables 1 and 2).  We used hierarchical cluster analysis of co-immunoprecipitated proteins in 126 
wild-type mice VNO or Nlgn3KOPvalbCre mice striatum or cerebellum but not in Nlgn3KO mice 127 
VNO to determine the optimal number of clusters in our dataset, which was found to be 128 
three. On this basis, follow-up two-step cluster analysis showed that cluster 1, 2 and 3 129 
contained 42.6%, 42.1% and 15.3% of co-immunoprecipitated proteins respectively (Figure 130 
1C). Analysis of the number of co-immunoprecipitated proteins contained in each cluster 131 
revealed that cluster 1 proteins almost uniquely originated from the striata and cluster 2 132 
proteins originated from the three anatomical regions (Figure 1D). Interestingly, cluster 3 133 
was mostly composed of proteins co-immunoprecipitated from striata and/or cerebella but 134 
not VNOs, suggesting the existence of proteins interacting with Neuroligin-3 specifically in 135 
neurons. Consistent with Neuroligin-3 synaptic localization in neurons, excitatory (PSD93 136 
and 95 and synapse-associated protein 97 and 102) and inhibitory synaptic proteins 137 
(Neuroligin-2 and-4 and gephyrin) were co-immunoprecipitated only in Pvalb-expressing 138 
neurons independently of the brain region (Supplementary Table 3). As FMRP, WAS Protein 139 
Family Member 1 (WASF1) and ABI1 were detected in proteins immunoprecipitated by 140 
Neuroligin-3. FMRP was detected in Nlgn3KOPvalbCre mice cerebella and striata whereas 141 
WASF1 and ABI1 were only detected in striata (Supplementary Table 3). These results 142 
suggest that binding between Neuroligin-3 and CYFIP1 and WRC is influenced by the 143 
localization of the Pvalb-expressing cells (Supplementary Table 3). Interestingly, the protein 144 
products of genes reliably associated with syndromic and non-syndromic ASD (with an SFARI 145 
gene score of 1, 2 or 3) were also co-immunoprecipitated only in Pvalb-expressing 146 
interneurons, independently of the brain region (Figure 1E). Altogether, these results show 147 
that Neuroligin-3 and CYFIP1 interact in neurons in vivo and that the identity of the protein 148 
they interact with is influenced by the regional localization of the neurons. Moreover, they 149 
suggest that CYFIP1 may interact with other ASD-associated proteins at excitatory and 150 
inhibitory synapses, either directly or indirectly via its binding to Neuroligin-3 151 
(Supplementary Figure 1B). 152 
Mice lacking Fmr1 or Nlgn3 show behavioral phenotypes associated with the core symptoms 153 
of ASD, including defects in social behavior, but also with some of its comorbidities (e.g. 154 
hyperactivity, alteration of motor learning)21, 25, 31-34. We hypothesized that since CYFIP1 155 
interacts with both Neuroligin-3 and FMRP, the behavioral phenotype should be similar 156 
across the three models. A complete absence of Cyfip1 is embryonic lethal7, therefore we 157 
used a model of Cyfip1 haploinsufficiency (Cyfip1HET). Cyfip1HET mice showed an absence of 158 
interest for social cues compared to their Cyfip1WT littermates (Figure 2A) without deficits in 159 
social dominance (courtship vocalization test, figure 2B) or repetitive behaviors (marble 160 
burying test, figure 2C). In addition, Cyfip1HET mice showed motor learning deficits, as 161 
indicated by the absence of an improved performance in the rotarod test, compared to their 162 
Cyfip1WT littermates (Figure 2D) but no change in basal motor activity (Figure 2E and F). The 163 
biochemical characterization of Cyfip1HET mice showed a significant decrease of CYFIP1 164 
protein expression levels in motor and frontal cortex and in the hippocampus but no change 165 
in other brain regions or in the periphery (Supplementary Figure 3). Cyfip1HET mice 166 
phenotype is consistent with the region-specific decrease of Cyfip1 protein expression since 167 
frontal and motor areas of the cortex are involved in the control of social and motor 168 
functions. In addition, the behavioral phenotype of Cyfip1HET mice is also consistent with the 169 
association between CYFIP1 and 15q11.2 deletion syndrome and ASD in humans, therefore 170 
validating the use of the mouse models for ASD studies.  171 
Cyfip1HET hippocampal neurons show deficits in dendritic spine maturation in vitro and ex 172 
vivo 9, a converging cellular phenotype between syndromic and non-syndromic genetic 173 
mouse models for ASD10, 11. Decreased dendritic spine maturation can be explained by 174 
defects in dendritic spine formation and/or dendritic spine instability. To investigate these 175 
two possibilities, we crossed Cyfip1HET mice with mice expressing green fluorescent proteins 176 
in a subset of neurons (refer to Material and Methods section) and imaged dendritic spines 177 
of cortical neurons ex vivo and in vivo in adult male mice. Immunohistology experiments 178 
demonstrated that Cyfip1HET mice showed decreased dendritic spine density in neurons from 179 
motor cortex but not from the V1 area of the visual cortex, compared to their Cyfip1WT 180 
littermates (Figure 3A). Two-photon imaging to track dendritic spines in the motor cortex in 181 
vivo revealed an increased formation and elimination of dendritic spines over time, in 182 
Cyfip1HET mice, compared to Cyfip1WT littermates (Figure 3B and C). Since increased rotarod 183 
performance correlates with increased formation of dendritic spines35, we hypothesized 184 
that, in addition to increased dendritic spine instability, Cyfip1HET mice show defects in 185 
dendritic spine formation. As previously demonstrated35, motor training increased the 186 
formation of dendritic spines by about three-fold in Cyfip1WT mice without affecting the 187 
number of eliminated spines (Figure 3D). Despite their lack of increased performance on the 188 
rotarod, Cyfip1HET mice showed an increased number of newly formed dendritic spines upon 189 
motor training similar to that of their Cyfip1WT littermates (Figure 3D). Note that rotarod 190 
training had no effect on dendritic spine elimination in both genotypes. These results show 191 
that while Cyfip1 haploinsufficiency does not impact on the ability to form new spines it 192 
leads to an increased dendritic spines instability. 193 
Given that Cyfip1HET show similar ability to form new spines upon training than wild-type 194 
mice, we hypothesized that training Cyfip1HET mice during the development, before the 195 
appearance of the behavioral phenotype, would be sufficient to rescue their motor learning 196 
deficits. The earliest time point in the development animals complied with the motor 197 
learning protocol was postnatal day 40 (P40), when wild-type mice show reliable decreased 198 
latency to fall from an accelerating rod over successive trials (Figure 4A). At P40, Cyfip1HET 199 
mice showed a decreased latency to fall from the accelerating rod over successive trials 200 
(Figure 4B). These results indicate that Cyifp1HET mice motor learning deficits develop after 201 
P40. To test our hypothesis we trained wild-type and Cyfip1HET mice at postnatal days 40, 50 202 
and 51 using the same rotarod protocol (in the following referred to as ‘trained’ mice) and 203 
tested for their motor behavior at P60. Trained wild-type mice showed an increased latency 204 
to fall from an accelerating rod at trial 1 and 2 and no difference at the subsequent trials 205 
compared to untrained wild-type mice, indicating that, as previously demonstrated35, motor 206 
training increased the basal motor performance of wild-type mice (Figure 4C). Trained 207 
Cyfip1HET mice showed a similar latency to fall from an accelerating rod from trial 1 to 4 and 208 
subsequently increased latency to fall compared to untrained Cyfip1HET mice, suggesting that 209 
sustained motor training during the development is sufficient to alleviate the motor deficits 210 
of adult Cyfip1HET mice (Figure 4D).   211 
Discussion 212 
Three important conclusions can be drawn from this study. First, we found that CYFIP1 binds 213 
to Neuroligin-3 at synapses and, directly or indirectly, to other proteins associated with ASD. 214 
Second, we showed that Cyfip1 haploinsufficiency is associated with alterations of dendritic 215 
spine stability, but not formation, and defects in social behavior and motor learning. Finally, 216 
based on these findings we designed a behavioral approach that alleviated the motor 217 
learning phenotype of Cyfip1HET mice. 218 
Dendritic spine defects as a converging phenotype in ASD 219 
Previous work with genetic mouse models suggested that the different genetic mutations 220 
associated with ASD target a small set of molecular pathways, leading to a deficit in dendritic 221 
spine morphogenesis 10, 11. Our study is the first to provide direct evidence to support this 222 
hypothesis. Importantly, defects in dendritic spine morphology are also reported in human 223 
post-mortem studies, showing that this pathophysiological feature is one of the few 224 
conserved between mouse models and humans.  225 
When studied in isolation, the impact of studies focusing on specific monogenic genetic risk 226 
factors for ASD is limited by the frequency of the mutations in the human population, which 227 
is, in general, very low 36. Our results demonstrate that some of these risk factors are in fact 228 
directly connected, such that they are likely to form a single molecular pathway in which 229 
dysfunction can cause specific forms of ASD. The frequency of such molecular alterations is 230 
likely to be equivalent to the sum of the frequency of the genetic risks, thus accounting for a 231 
large number of individuals with ASD. It remains possible that independent pathways 232 
regulating dendritic spine formation and function may alter the composition of this cluster 233 
of ASD proteins, suggesting that, not all cases of ASD associated where such changes are 234 
present, can be attributed to a single cause. Nevertheless, this finding is likely to provide a 235 
framework to address the genetic heterogeneity associated with ASD.  236 
As such, analysis of dendritic spine morphology or density cannot be conveniently used as a 237 
biomarker in the human population, as it requires access to brain tissue. In this context, our 238 
findings are more likely to represent a step towards a better definition of some of the 239 
biological basis of ASD, which in turn may lead to the identification of biological markers. 240 
Indeed, dendritic spines are the postsynaptic docking compartment for a large number of 241 
excitatory synapses and decrease in their number and stability is likely to have a direct 242 
consequence on the number of synaptic inputs a neuron receives and, by extension, a brain 243 
region receives. Such connectivity between brain regions can be quantified in mice and 244 
humans using diffusion tensor imaging. Using Cyfip1Het mouse model, and by extension, any 245 
genetic model associated with the ASD protein cluster could, therefore, help to better 246 
understand the complex relationship between brain region-specific defects in dendritic 247 
spine stability and brain-wide connectivity providing an experimental framework to identify 248 
biological markers for specific behavioral phenotypes.  249 
Predicted functional consequences associated with the ASD cluster of proteins 250 
Aberrant signaling through type 1 metabotropic glutamate receptors 1 and 5 (mGluR1 and 251 
5), resulting in defects in long-term synaptic depression (LTD), is a pathophysiological 252 
hallmark of genetic mouse models of ASD 37. Interestingly, mutations in genes associated 253 
with the proteins co-immunoprecipitated with Neuroligin-3 , including Neuroligin-3 itself (32, 254 
38 but see 39), CYFIP18, FMRP 40, MeCP2 41, Synaptic Ras GTPase-activating protein 1 (encoded 255 
by the Syngap1 gene) 42 and the beta 3 subunit of Type A Gamma-Aminobutyric Acid 256 
receptors (encoded by the Gabrb3 gene) 43, lead to such phenotypes. These results indicate 257 
that in addition to regulating dendritic spine morphogenesis, this cluster of proteins might 258 
be involved in regulation of mGluR1/5 function and control of LTD.  259 
At synapses, mGluR1/5 binds directly to Homer proteins, which links the receptors to the 260 
endoplasmic reticulum (ER), via interactions with PI 3-Kinase Enhancer (PIKE) and Inositol 261 
1,4,5-Trisphosphate receptors (IP3Rs), or to ionotropic glutamate receptors, via SH3 and 262 
multiple ankyrin repeat domains (Shank) proteins 44. Our data show that type 1 mGluR, and 263 
mGluR1 specifically, are reliably co-immunoprecipitated with Neuroligin-3 in cerebellar but 264 
not striatal Pvalb-expressing cells (Supplementary Table 3). Moreover, along with mGluR1 265 
we also reliably detected PIKE (encoded by the Agap3 gene) and IP3R1 (encoded by the Itpr1 266 
gene) but not Shank proteins or ionotropic receptors (Supplementary Table 3).  Interestingly, 267 
FMPR has been shown to inhibit PIKE and therefore type 1 mGluR downstream signalling45. 268 
These results raise the question of a potential involvement of CYFIP1 in regulating type 1 269 
mGluR downstream signaling. It is possible that Neuroligin-3, FMRP, and CYFIP1 are 270 
expressed in different subcellular compartments of the neurons and, therefore, do not 271 
aggregate in a single cluster. Nevertheless, these results suggest that Neuroligin-3, FMRP, 272 
and CYFIP1 are involved in localizing mGluR1 and the ER at the synapse. The release of 273 
calcium from the ER to the cytoplasm is regulated by mGluR1 and essential for the induction 274 
of LTD 46. Based on our results, we can further speculate that defects in mGluR-LTD observed 275 
in genetic mouse models for ASD result from an inappropriate localization of the mGlur/ER 276 
complex at the synapse, a hypothesis that remains to be experimentally tested. Importantly, 277 
this mechanism might be cell or type 1 mGluR specific as we did not reliably detect type 1 278 
mGluR in proteins co-immunoprecipitated with Neuroligin-3 in the striatum.   279 
Behavioral treatment to alleviate ASD core and comorbid symptoms 280 
About 42% of Individuals carrying 15q11.2 deletions show motor delay2. Motor 281 
abnormalities and delay in motor development are common comorbid symptoms in more 282 
than 70% of individuals with ASD1. In this study, we found that adult Cyfip1HET mice show 283 
defects in motor learning. Note that we have not fully characterized the motor learning 284 
deficits and it is possible that a less challenging paradigm, with longer interatrial intervals for 285 
example, would find milder or no phenotype in Cyfip1HET mice. Nevertheless, Along with 286 
Cyfip1HET mice, other mouse models for ASD show motor phenotypes47, suggesting that, to a 287 
certain extent, mouse models of ASD replicate motor abnormalities found in humans. 288 
Importantly, we found that training Cyfip1HET mice early in the development is sufficient to 289 
alleviate the motor learning phenotype in adult mice. These results demonstrate that the 290 
motor learning phenotype of Cyfip1HET mice develops over time, appearing between young 291 
adult and adult stages, and is reversible using behavioural training approaches. As future 292 
studies, it would be interesting to know if dendritic spine phenotypes follow the similar 293 
developmental trajectories and sensitivity to behavioural training. These results provide 294 
important insights for the treatment of motor impairment in ASD in humans. In humans, 295 
motor impairments can be detected early in the development alongside the diagnosis of 296 
ASD. Our results suggest that early behavioral intervention, targeted at stimulating motor 297 
function, might help in preventing motor impairment arising later in life.  298 
 299 
 300 
  301 
Materials and Methods 302 
Animals 303 
All procedures were conducted in accordance with the Animals (Scientific Procedures) Act 304 
1986 (amended 2012). Nlgn3KO mice 48 were crossed with OmpCre mice (JAX: #006668, 49), 305 
where part of the Omp gene was replaced by Cre recombinase.  Nlgn3KO mice were also 306 
crossed with PvalbCre mice, expressing Cre recombinase under the Pvalb promoter 307 
(JAX:017320 50). The Cyfip1tm2a(EUCOMM)Wtsi (EUCOMM) mouse line was either bred with BL6 308 
mice to obtain Cyfip1Het and Cyfip1WT mice or crossed with Tg(Thy1-EGFP)MJrs/J (JAX: # 309 
007788, 51) to obtain Thy1-EGFP-Cyfip1Het and Thy1-EGFP-Cyfip1WT mice. Mice were kept on a 310 
12 h light/dark cycle with free access to food and water. All behaviors were assessed during 311 
the light cycle and after mice were habituated for 30 min to the testing room.  312 
Biochemistry 313 
Brain tissue from adult mice was sliced in 1.5 mm - 2 mm sections and micro dissected prior 314 
to snap freezing and storage at -80°C. 10 µl of lysis buffer (1% SDS, 10 mM Hepes, Protease 315 
inhibitors, Phosphatase inhibitors, 1 mM  NaF, 1 mM NaVO4) was used per 1 mg of tissue. 316 
Using Laemmli buffer samples were run on SDS-PAGE gels (NuPAGE Novex 4-12% Bis-Tris, 317 
Protein gels, Invitrogen) and transferred on nitrocellulose membrane. Immunoblotting was 318 
performed with antibodies raised against CYFIP1 (Anti-CYFIP1 ab156016, Abcam), β-III 319 
Tubulin (801201, BioLegend) and GAPDH (83956, Abcam). Blots were developed using ECL 320 
(Santa Cruz and Advansta). Blots were digitally acquired by ChemiDoc (Biorad) and 321 
quantified using Image Lab Software (Biorad). 322 
For synaptosome fractionation, mice were culled by cervical dislocation, and the brains were 323 
immediately dissected and homogenized in SynPer (Sigma-Aldrich) containing protease 324 
cocktail inhibitors (Sigma-Aldrich) and phosphatase inhibitors (10mM NaF, 1mM NaVO4).  325 
Homogenized tissues were then centrifuged to give pellets, resuspended in SynPer to obtain 326 
nuclear fractions, and supernatants (i.e. homogenates). Part of the supernatants was further 327 
centrifuged to give pellets, further resuspended in SynPer® to give synaptosome fractions 328 
and cytosolic fractions in supernatants. The samples were then immediately processed for 329 
western blot analysis, or immediately used for immunoprecipitation experiments.   330 
For immunoprecipitation, tissues were dissected and then homogenized in 100 mL of lysis 331 
buffer for each 10 mg of tissue (20 mM Tris-HCL, 150 mM NaCl, 1 mM EDTA, 1% Triton-X100, 332 
10 mM NaF, 1 mM Na3VO4, protease inhibitor cocktail (Sigma-Aldrich)). The samples were 333 
centrifuged at 14000g for 10 min at 4°C and the supernatant containing the proteins was 334 
removed. The ethanol was removed from Sepharose beads coated with Protein A (GE 335 
Healthcare Life Sciences) by two washes with ice-cold phosphate-buffered saline, at 2000g 336 
for 2 min. The supernatant was pre-cleared by incubating with Protein A-Sepharose beads 337 
for 30 min at 4°C. Protein A-Sepharose beads for immunoprecipitation were washed with 338 
lysis buffer at 2000g for 2 min. Proteins were then incubated for 2 h at 4°C with Protein A-339 
Sepharose beads and Neuroligin-3 antibody (#129311, Synaptic Systems, 1:1000).  Unbound 340 
proteins were removed by three washes with lysis buffer. Peptides were then eluted in 341 
lithium dodecyl sulfate buffer (106 mM Tris-HCl, 141 mM Tris-base, 2% LDS, 10% glycerol, 342 
0.51 mM EDTA, 0.22 mM Brilliant Blue, 0.175 mM Phenol Red, 10 mM DTT) at 70°C for 10 343 
minutes. Samples were frozen at -20°C for storage. 344 
Mass-spectrometry analysis 345 
Each sample was separated as a lane on an SDS-PAGE gel and electrophoresis was 346 
performed until the samples had run approximately 3cm into the separating gel. The gel lane 347 
was then cut into 3 slices and each slice subjected to in-gel tryptic digestion using a 348 
DigestPro automated digestion unit (Intavis Ltd.).  The resulting peptides were fractionated 349 
using an Ultimate 3000 nano-LC system in line with an LTQ-Orbitrap Velos mass 350 
spectrometer (Thermo Scientific).  In brief, peptides in 1% (vol/vol) formic acid was injected 351 
onto an Acclaim PepMap C18 nano-trap column (Thermo Scientific). After washing with 0.5% 352 
(vol/vol) acetonitrile 0.1% (vol/vol) formic acid peptides were resolved on a 250 mm × 75 μm 353 
Acclaim PepMap C18 reverse phase analytical column (Thermo Scientific) over a 150 min 354 
organic gradient, using 7  gradient segments (1-6% solvent B over 1min., 6-15% B over 355 
58min., 15-32%B over 58min., 32-40%B over 5min., 40-90%B over 1min., held at 90%B for 356 
6min and then reduced to 1%B over 1min.) with a flow rate of 300 ml.min−1.  Solvent A was 357 
0.1% formic acid and Solvent B was aqueous 80% acetonitrile in 0.1% formic acid.  Peptides 358 
were ionized by nano-electrospray ionization at 2.1 kV using a stainless-steel emitter with an 359 
internal diameter of 30 μm (Thermo Scientific) and a capillary temperature of 250°C. 360 
Tandem mass spectra were acquired using an LTQ- Orbitrap Velos mass spectrometer 361 
controlled by Xcalibur 2.1 software (Thermo Scientific) and operated in data-dependent 362 
acquisition mode.  The Orbitrap was set to analyze the survey scans at 60,000 resolution (at 363 
m/z 400) in the mass range m/z 300 to 2000 and the top twenty multiply charged ions in 364 
each duty cycle selected for MS/MS in the LTQ linear ion trap.  Charge state filtering, where 365 
unassigned precursor ions were not selected for fragmentation, and dynamic exclusion 366 
(repeat count, 1; repeat duration, 30s; exclusion list size, 500) were used.  Fragmentation 367 
conditions in the LTQ were as follows: normalized collision energy, 40%; activation q, 0.25; 368 
activation time 10ms; and minimum ion selection intensity, 500 counts. 369 
The raw data files were processed and quantified using Proteome Discoverer software v1.4 370 
(Thermo Scientific) and searched against the UniProt Mouse database (78740 sequences) 371 
using the SEQUEST algorithm. Peptide precursor mass tolerance was set at 10ppm, and 372 
MS/MS tolerance was set at 0.8Da.  Search criteria included carbamidomethylation of 373 
cysteine (+57.0214) as a fixed modification and oxidation of methionine (+15.9949) as a 374 
variable modification.  Searches were performed with full tryptic digestion and a maximum 375 
of 1 missed cleavage was allowed.  The reverse database search option was enabled and all 376 
peptide data was filtered to satisfy false discovery rate (FDR) of 5%.   377 
Social interest  378 
Social odors originated from two cages of three C57Bl/6 male mice with the different 379 
parental origins, maintained for 6 days with the same home cage bedding to allow for a 380 
concentration of odorants. Before the test, swabs were wiped in a zig-zag pattern across the 381 
bottom surface of the cage to collect the olfactory cues. Mice were acclimatized for 30 382 
minutes to the presence of a cotton swab prior to testing. Mice were then exposed to a 383 
cotton swab without odor followed by a cotton swab with a social odor. During the 2 384 
minutes exploration periods, the time spent sniffing the swab on the first exposure to each 385 
odor was recorded manually and blind to the genotype. 386 
Vocalization 387 
We recorded ultrasonic vocalization (USV) emitted by the male mice exposed to a female 388 
mouse in estrus (1, 2). All male mice were first habituated for 3 minutes to the arena. 389 
Following the habituation, an unfamiliar female mouse in estrus was added to the same 390 
arena for 3 minutes. During this time the mice could interact with each other freely in the 391 
arena. The male vocalization behavior was recorded by a preamplifier (UltraSoundGate 392 
416H, Avisoft Bioacoustics) connected microphone (UltraSoundGate CM16, Avisoft 393 
Bioacoustics) placed above the arena. As previously described frequencies were recorded 394 
and analyzed for the total number of emitted calls and the total time spent calling using 395 
SASLabPro (Avisoft Bioacoustics). 396 
Marble burying 397 
Mice were in individual cages (28 cm x 17 cm) each containing 20 marbles arranged in 5 398 
rows of 4 marbles on top of 4 cm deep bedding over the time course of 30 min. The testing 399 
room used was dimly lit, with equal light distribution for all mice in the trial. A marble was 400 
buried when ≤ 50% of the marble was not visible. For counting and quantification, 401 
experimenters were blind to the genotype. 402 
Rotarod behavior 403 
Prior to the experiment mice were handled over the course of two days. During a trial, the 404 
rod accelerated to 40 rpm within 5 min. The latency to fall was evaluated across 7 405 
subsequent trials with a rest period of 5 min in between. The latency to fall was determined 406 
based on the time spent on the rod until the test mouse fell off, gripped to the rod and 407 
followed the rod for a full rotation or the testing trial ends after 5 min. 408 
Activity and anxiety behavior  409 
Spontaneous activity of the mice was tested in an open field arena (40 cm x 40 cm) for 20 410 
minutes, in the dark. The mice were able to freely move and explore the environment during 411 
the test. The behavior was recorded by a computer linked video camera located above the 412 
arena. The arena was illuminated from the bottom by an infrared light source, for detection 413 
of the mice. EthoVision XT (Noldus) software was used for tracking and quantification of the 414 
average velocity.  415 
Immunohistology 416 
Thy-1 GFP-expressing Cyfip1WT and Cyfip1HET mice were anesthetized and perfused with 4% 417 
paraformaldehyde in 0.1 M phosphate buffer (PB). Brains were post-fixed overnight, stored 418 
in OCT at -80oC, then cut coronally into 50 μm sections on a cryostat (Leica Biosystems, 419 
Germany) and mounted on a series of glass slides. Confocal images were acquired on a Zeiss 420 
LSM700 upright confocal microscope (Carl Zeiss, Welwyn Garden City, UK), using a 43x water 421 
immersion lens (N.A = 1.3). At least 10 Z-stack images (2048 x 2048 pixels) spaced 0.5 μm 422 
apart were acquired in the primary motor and visual cortices of each animal, focusing on 423 
secondary branching dendrites from cells. Series stacks were reconstructed into two 424 
dimensions according to Z-stack projections of maximum intensity in ImageJ (NIH, USA, 425 
public domain). All images were coded at the time of acquisition and analyzed blinded to the 426 
experimental condition. Spines were manually identified and counted on 60-150 μm long 427 
dendrites, with N = 24 dendrites (from 4 mice) per condition analyzed. Spine density was 428 
calculated as the number of spines per 10 μm of dendrites. 429 
Structural plasticity imaging in vivo 430 
Dendritic spine imaging was performed in awake and head fixed Thy-1 GFP-expressing 431 
Cyfip1WT and Cyfip1HET adult male mice (from postnatal day 60) with implanted cranial 432 
windows. Aseptic surgical procedures were conducted based on previously described 433 
protocols35. Approximately one hour prior to cranial window surgery, animals were 434 
administered with the antibiotic Baytril (5 mg/kg, s.c.) and the anti-inflammatory drugs 435 
Carprofen (5 mg/kg, s.c.) and Dexamethasone (0.15 mg/Kg, i.m.). Anesthesia was induced 436 
then maintained using isoflurane at concentrations of 4%, then 1.5-2% respectively. After 437 
animals were secured in a stereotaxic frame, the scalp and periosteum were removed from 438 
the dorsal surface of the skull, and a custom head plate was attached to the cranium using 439 
dental cement (Super Bond C&B), with an aperture approximately centered over right M1. A 440 
3 mm circular craniotomy was next performed, centered over the forelimb area using 441 
stereotaxic coordinates 1.3 mm anterior to the bregma and 1.2 mm lateral from the 442 
midline. The craniotomy was then closed with a glass insert constructed from 3 layers of 443 
circular no.1 thickness glass (1x5 mm, 2x3 mm diameter) bonded together with an optical 444 
adhesive (Norland Products; catalog no. 7106). Mice were imaged one-week post-surgery. 445 
Initial dendritic spine imaging was followed up after two, seven and nine days. In vivo 2-446 
photon imaging was performed using a resonant scanning microscope (Thorlabs, B-Scope) 447 
with a 16x 0.8NA objective with 3 mm working distance (Nikon). eGFP was excited at 980 nm 448 
using a Ti:sapphire laser (Coherent, Chameleon) with a maximum laser power at a sample of 449 
20 mW. Z stacks were acquired at a frame rate of approximately 30 Hz, with 20 frames per 450 
depth, from 15 depths spaced by 2 µm. Imaged stretches of dendrite close to parallel to the 451 
imaging plane were selected based on an eGFP expression which was traced back to the 452 
soma located in layer 5 (Z: 400 µm – 500 µm from brain surface). Cortical surface vascular 453 
landmarks were used to locate the same stretches of dendrite between sessions. During 2-454 
photon imaging animals were free to run on a custom designed fixed axis cylindrical 455 
treadmill, and data collection was limited to stationary periods to avoid locomotion related 456 
brain movement. Imaging data were acquired using Scanimage 4.1 (HHMI Janelia). Imaging 457 
data were first corrected for brain motion using an automated rigid registration algorithm 458 
implemented in Matlab (MathWorks). The 20 frames from each depth were then averaged 459 
and a maximum intensity projection calculated over the z planes which encompassed the 460 
stretch of the dendrite of interest. Formed and eliminated spines were manually counted 461 
and normalized to 100 µm of dendrite (Thy1-EGFP-Cyfip1Het N = 36, from 4 mice; Thy1-EGFP-462 
Cyfip1WT N = 40, from 4 mice). 463 
Statistical analysis 464 
Prior the cluster analysis, every protein detected in immunoprecipitates from VNO of 465 
Nlgn3KO mice (Supplementary Table 2) was filtered out of the ones immunoprecipitated 466 
from wild-type mice VNO (Supplementary Table 2) and Nlgn3KOPvalbCre striatum and 467 
cerebellum (Supplementary Table 1), because proteins present in Nlgn3KO are likely to be 468 
false positives. The list of remaining proteins can be found in Supplementary Table 3. A 469 
protein was considered detected when its score was > 0, therefore obtaining a binarized 470 
dataset containing proteins detected (score of 1) and non-detected (Score of 0) for each 471 
technical triplicate and each anatomical region. We used SPSS Statistics® software to 472 
perform hierarchical cluster analysis based on the binarized score and determined that three 473 
clusters described the dataset best. We then performed a two-step analysis with three 474 
clusters and obtained the results presented in Figure 1.  475 
Supplementary Table 4 contains the data structure, type of test used, observed power and N 476 
for Figure 3 and 4. Each test included enough animals to reach a power close to or above 477 
0.8. We designed our tests groups to have mice from the different groups tested at the same 478 
time. We used SPSS Statistics® software to systematically test for normality using Levene’s 479 
test. No animals were removed from the analyses. Pairwise comparisons were analyzed by 480 
two-tailed Student’s t-test for normally distributed datasets or two-tailed Mann Whitney’s 481 
test for non-normally distributed datasets. All datasets used for two-way non-repeated and 482 
repeated measure ANOVAs were normally distributed and, when appropriate, followed by 483 
post-hoc Bonferroni’s test.  484 
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Figure 1. Binding between Neuroligin-3 and Cyfip1 in Pvalb-expressing neurons. A. 717 
Western blot analysis showing that Neuroligin-1, 2 and 3 (NL1, 2 and 3) and Cyfip1 are 718 
detected in proteins co-immunoprecipitated with Neuroligin-3 in wild-type striatum (St), 719 
cerebellum (Cb) and cortex (Cx). Note that FMRP is not detected in co-immunoprecipitated 720 
proteins. B. Western blot analysis showing that Neuroligin-2 (NL2), Cyfip1 and FMRP are 721 
detected in proteins co-immunoprecipitated with Neuroligin-3 in striatum (St), cerebellum 722 
(Cb) and cortex (Cx) of Nlgn3KOPvalbCre mice. Note that Neuroligin-1 was not detected in co-723 
immunoprecipitated proteins. C. Two-step cluster analysis of proteins co-724 
immunoprecipitated with Neuroligin-3 in wild-type mice VNO, Nlgn3KOPvalbCre striatum (St) 725 
and cerebellum (Cb) but not in Nlgn3KO mice VNO. D. Bar graphs show the number of 726 
proteins per cluster and per anatomical region. E. Details of the anatomical region (VNO (V), 727 
striatum (S) or cerebellum (C)) and cluster in which proteins coded by genes associated with 728 
ASD and co-immunoprecipitated with Neuroligin-3 are detected. 729 
 730 
Figure 2. Cyfip1 haploinsufficiency leads to motor learning defects. A. Cyfip1HET mice spent 731 
a similar amount of time sniffing control, non-social, odor (C) and social odor (S), whereas 732 
their Cyfip1WT littermate spent more time sniffing the social odor (S) than the control one 733 
(C).  B. Cyfip1HET mice and their Cyfip1WT littermates spent a similar amount of time calling 734 
when exposed to females in estrus. C. Cyfip1HET mice and their Cyfip1WT littermates buried a 735 
similar number of marbles. D. The time Cyfip1WT mice spent on an accelerating rotarod 736 
significantly increased over seven trials, whereas that of Cyfip1HET did not. E. Cyfip1WT and 737 
Cyfip1HET mice spent similar amounts of time on an accelerating rotarod on the first trial. F. 738 
Cyfip1WT and Cyfip1HET mice’s velocity in the open field was similar. In A, connected dots 739 
represent the same animal tested for the control (C) and the social (S) odors. All values in B-740 
D are represented as mean ± SEM. In A and D, statistical significance was tested by repeated 741 
measures ANOVA followed by Bonferroni Post-hoc test. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001 742 
and **** P ≤ 0.0001. In B, C, E, and F, statistical significance was tested by two-tailed 743 
Student’s t-test or one-tailed Mann-Whitney test.  744 
 745 
Figure 3. Cyfip1 haploinsufficiency leads to decreased stability of dendritic spines without 746 
affecting their formation. A. Dendrites of GFP-expressing neurons from the motor cortex 747 
(M1), visual cortex (V1) and hippocampus (CA1 and CA3) of Cyfip1WT and Cyfip1HET mice. 748 
Scale bars represent 10μm. Quantification of spine density of Cyfip1WT and Cyfip1HET 749 
dendrites. B. Two images of the same dendrite of a Cyfip1WT mice motor neuron taken at an 750 
interval of two days showing the newly formed dendritic spines (arrows). Scale bars 751 
represent 2 μm. C. Quantification of formed and eliminated dendritic spines in motor 752 
cortices of Cyfip1WT and Cyfip1HET mice. D. Quantification of formed dendritic spines in motor 753 
cortices of Cyfip1WT and Cyfip1HET mice before (B) and after rotarod training (R). All values 754 
are represented as mean ± SEM. In B and D, statistical significance was tested by ANOVA 755 
followed by Bonferroni post-hoc test. **P ≤ 0.01. In E, statistical significance was tested by 756 
repeated measures ANOVA followed by Bonferroni post-hoc test. 757 
 758 
Figure 4. Motor training at early stages of development alleviates Cyfip1HET motor deficits. 759 
A-B. Wild-type and Cyfip1HET male mice improved their latency to fall off the accelerating rod 760 
at P40. C. Trained Cyfip1WT mice showed increased motor performances during the first two 761 
trials during the behavioral assessment at P60 compared to untrained adult wild-type mice.  762 
D. Trained Cyfip1HET mice increased their motor performances during the rotarod testing 763 
compared to untrained Cyfip1HET mice. All values presented as mean ± SEM. Statistical 764 
significance was tested by repeated measures ANOVA followed by Bonferroni post-hoc test. 765 
*P < 0.05; **P < 0.01; ***P < 0.001.  766 
 767 
 768 




